Yescarta (axicabtagene ciloleucel) has been approved as a treatment for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

A young Leitrim mother and lymphoma survivor whose cancer symptoms were first attributed to an allergic reaction to her lip ...

Young mother and lymphoma survivor, Letitia McFarlane, urges Leitrim community to go all in against cancer this Daffodil Day.

修订要点如下：(1)淋巴瘤的诊断和初始分期中，修改了滤泡性淋巴瘤(follicular lymphoma， FL)、自然杀伤(natural killer， NK)/T细胞淋巴瘤等的推荐水平，新增原发性皮肤细胞淋巴瘤等；(2)淋巴瘤中期再次分期和疗效评估中，新增原发纵隔大B细胞淋巴瘤 ...

Histology revealed no malignancy in one patient and lymphoma in another, both of whom had negative miR371a findings ... The locations of the observed relapses were: Pulmonary Mediastinal Pelvic ...